An Acidic Environment Induces APOL1-Associated Mitochondrial Fragmentation.
African American
Apolipoprotein L1 gene
Chronic kidney disease
Focal segmental glomerulosclerosis
Interstitial pH
Mitochondria
Journal
American journal of nephrology
ISSN: 1421-9670
Titre abrégé: Am J Nephrol
Pays: Switzerland
ID NLM: 8109361
Informations de publication
Date de publication:
2020
2020
Historique:
received:
08
04
2020
accepted:
03
07
2020
pubmed:
1
9
2020
medline:
20
7
2021
entrez:
1
9
2020
Statut:
ppublish
Résumé
Apolipoprotein L1 gene (APOL1) G1 and G2 kidney-risk variants (KRVs) cause CKD in African Americans, inducing mitochondrial dysfunction. Modifying factors are required, because a minority of individuals with APOL1 high-risk genotypes develop nephropathy. Given that APOL1 function is pH-sensitive and the pH of the kidney interstitium is <7, we hypothesized the acidic kidney interstitium may facilitate APOL1 KRV-induced mitochondrial dysfunction. Human embryonic kidney (HEK293) cells conditionally expressing empty vector (EV), APOL1-reference G0, and G1 or G2 KRVs were incubated in media pH 6.8 or 7.4 for 4, 6, or 8 h. Genotype-specific pH effects on mitochondrial length (µm) were assessed using confocal microscopy in live cells and Fiji derivative of ImageJ software with MiNA plug-in. Lower mitochondrial length indicated fragmentation and early dysfunction. After 6 h doxycycline (Dox) induction in pH 6.8 media, G2-expressing cells had shorter mitochondria (6.54 ± 0.40) than cells expressing EV (7.65 ± 0.72, p = 0.02) or G0 (7.46 ± 0.31, p = 0.003). After 8 h Dox induction in pH 6.8 media, both G1- (6.21 ± 0.26) and G2-expressing cells had shorter mitochondria (6.46 ± 0.34) than cells expressing EV (7.13 ± 0.32, p = 0.002 and p = 0.008, respectively) or G0 (7.22 ± 0.45, p = 0.003 and p = 0.01, respectively). Mitochondrial length in cells incubated in pH 7.4 media were comparable after 8 h Dox induction regardless of genotype. APOL1 mRNA expression and cell viability were comparable regardless of pH or genotype after 8 h Dox induction. Acidic pH facilitates early mitochondrial dysfunction induced by APOL1 G1 and G2 KRVs in HEK293 cells. We propose that the acidic kidney interstitium may play a role in APOL1-mediated mitochondrial pathophysiology and nephropathy.
Sections du résumé
BACKGROUND
Apolipoprotein L1 gene (APOL1) G1 and G2 kidney-risk variants (KRVs) cause CKD in African Americans, inducing mitochondrial dysfunction. Modifying factors are required, because a minority of individuals with APOL1 high-risk genotypes develop nephropathy. Given that APOL1 function is pH-sensitive and the pH of the kidney interstitium is <7, we hypothesized the acidic kidney interstitium may facilitate APOL1 KRV-induced mitochondrial dysfunction.
METHODS
Human embryonic kidney (HEK293) cells conditionally expressing empty vector (EV), APOL1-reference G0, and G1 or G2 KRVs were incubated in media pH 6.8 or 7.4 for 4, 6, or 8 h. Genotype-specific pH effects on mitochondrial length (µm) were assessed using confocal microscopy in live cells and Fiji derivative of ImageJ software with MiNA plug-in. Lower mitochondrial length indicated fragmentation and early dysfunction.
RESULTS
After 6 h doxycycline (Dox) induction in pH 6.8 media, G2-expressing cells had shorter mitochondria (6.54 ± 0.40) than cells expressing EV (7.65 ± 0.72, p = 0.02) or G0 (7.46 ± 0.31, p = 0.003). After 8 h Dox induction in pH 6.8 media, both G1- (6.21 ± 0.26) and G2-expressing cells had shorter mitochondria (6.46 ± 0.34) than cells expressing EV (7.13 ± 0.32, p = 0.002 and p = 0.008, respectively) or G0 (7.22 ± 0.45, p = 0.003 and p = 0.01, respectively). Mitochondrial length in cells incubated in pH 7.4 media were comparable after 8 h Dox induction regardless of genotype. APOL1 mRNA expression and cell viability were comparable regardless of pH or genotype after 8 h Dox induction.
CONCLUSION
Acidic pH facilitates early mitochondrial dysfunction induced by APOL1 G1 and G2 KRVs in HEK293 cells. We propose that the acidic kidney interstitium may play a role in APOL1-mediated mitochondrial pathophysiology and nephropathy.
Identifiants
pubmed: 32866949
pii: 000509989
doi: 10.1159/000509989
pmc: PMC7511450
mid: NIHMS1613057
doi:
Substances chimiques
APOL1 protein, human
0
Apolipoprotein L1
0
Culture Media
0
Recombinant Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
695-704Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK070941
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK084149
Pays : United States
Organisme : NIMHD NIH HHS
ID : R01 MD009055
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG051866
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 S. Karger AG, Basel.
Références
Cells. 2019 Feb 19;8(2):
pubmed: 30791381
Nat Med. 2013 Nov;19(11):1371-2
pubmed: 24202384
Nutrients. 2018 May 11;10(5):
pubmed: 29751620
Kidney Int Rep. 2020 Mar 30;5(6):891-904
pubmed: 32518871
Commun Biol. 2019 Apr 26;2:144
pubmed: 31044169
Nat Med. 2017 Apr;23(4):429-438
pubmed: 28218918
Sci Rep. 2017 Nov 1;7(1):14864
pubmed: 29093569
Acta Histochem. 2017 Apr;119(3):315-326
pubmed: 28314612
Redox Biol. 2018 May;15:394-404
pubmed: 29331741
Am J Transplant. 2011 May;11(5):1025-30
pubmed: 21486385
J Am Soc Nephrol. 2014 Oct;25(10):2254-66
pubmed: 24700866
Am J Physiol. 1988 Aug;255(2 Pt 2):F301-6
pubmed: 2841871
J Biol Chem. 1997 Oct 10;272(41):25576-82
pubmed: 9325276
J Ren Nutr. 2018 Jul;28(4):251-258
pubmed: 29751994
J Cell Biol. 1989 Sep;109(3):1279-88
pubmed: 2549077
PLoS One. 2016 Apr 07;11(4):e0152775
pubmed: 27054572
J Am Soc Nephrol. 2017 Apr;28(4):1093-1105
pubmed: 27821631
J Am Soc Nephrol. 2020 Mar;31(3):469-482
pubmed: 31988269
J Am Soc Nephrol. 2017 Apr;28(4):1117-1130
pubmed: 27864431
Proc Natl Acad Sci U S A. 2007 May 8;104(19):7893-8
pubmed: 17483464
Front Endocrinol (Lausanne). 2014 Dec 15;5:209
pubmed: 25566185
Front Oncol. 2013 Dec 02;3:292
pubmed: 24350057
JCI Insight. 2017 Jul 20;2(14):
pubmed: 28724794
J Am Soc Nephrol. 2015 Feb;26(2):339-48
pubmed: 25012173
J Am Soc Nephrol. 2017 Nov;28(11):3227-3238
pubmed: 28696248
J Lipid Res. 2015 Aug;56(8):1583-93
pubmed: 26089538
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Cell Rep. 2020 Mar 17;30(11):3821-3836.e13
pubmed: 32187552
Sci Rep. 2017 Sep 5;7(1):10492
pubmed: 28874733
Am J Physiol. 1992 Oct;263(4 Pt 2):F749-56
pubmed: 1415745
J Am Soc Nephrol. 2017 Apr;28(4):1079-1083
pubmed: 27932478
J Am Soc Nephrol. 2011 Nov;22(11):2119-28
pubmed: 21997392
Transl Psychiatry. 2013 Oct 29;3:e321
pubmed: 24169640
J Clin Invest. 2002 Jan;109(1):89-99
pubmed: 11781354
Genes Dev. 2008 Jun 15;22(12):1577-90
pubmed: 18559474
Biosci Rep. 2018 Aug 29;38(4):
pubmed: 29967295
Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2894-9
pubmed: 25730870
J Am Soc Nephrol. 2019 Dec;30(12):2355-2368
pubmed: 31558683
Am J Physiol. 1979 Mar;236(3):F240-5
pubmed: 34325
J Am Soc Nephrol. 2013 Sep;24(9):1484-91
pubmed: 23766536
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Biol Chem. 2017 Nov 3;292(44):18344-18353
pubmed: 28918394
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Am J Nephrol. 2018;47(3):174-181
pubmed: 29525790
Am J Physiol Renal Physiol. 2015 Jul 15;309(2):F120-36
pubmed: 25972512
Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1291-1296
pubmed: 29490976
Kidney Int Rep. 2019 Apr 04;4(7):946-954
pubmed: 31317117